Financial Information of Studio LSD Limited IPO
The Revenues from operations for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 10,500.70 Lakh, ₹ 10,249.48 Lakh and ₹ 4,671.22 Lakh. The EBITDA for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 1,604.28 Lakh, ₹ 1,484.46 Lakh and ₹ 377.97 Lakh. The Profit after Tax for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 1,167.00 Lakh, ₹ 1,090.37 Lakh and ₹ 279.50 Lakh respectively. This indicates a steady growth in financial performance.
Period Ended | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
---|---|---|---|
Reserve of Surplus | 1,935.88 | 1,585.52 | 495.15 |
Total Assets | 4,666.89 | 3,648.54 | 1,815.94 |
Total Borrowings | 12.99 | - | 6.15 |
Fixed Assets | 52.94 | 76.52 | 25.89 |
Cash | 232.74 | 572.92 | 58.07 |
Net Borrowing | -219.75 | -572.92 | -51.92 |
Revenue | 10,500.70 | 10,249.48 | 4,671.22 |
EBITDA | 1,604.28 | 1,484.46 | 377.97 |
PAT | 1,167.00 | 1,090.37 | 279.50 |
EPS | 2.85 | 2.67 | 0.68 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue, given in RHP.
Copyright @2020 Design & Developed by Info Web Software